These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 16757924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K.
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [Abstract] [Full Text] [Related]

  • 3. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Magy Onkol; 2006 Sep; 50(4):329-35. PubMed ID: 17216007
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
    Dille MF, McMillan GP, Reavis KM, Jacobs P, Fausti SA, Konrad-Martin D.
    J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
    [Abstract] [Full Text] [Related]

  • 6. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR, Kraemer DF, Winter C, Neuwelt EA.
    J Clin Oncol; 2007 Apr 01; 25(10):1190-5. PubMed ID: 17401008
    [Abstract] [Full Text] [Related]

  • 7. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M.
    Otolaryngol Pol; 2006 Apr 01; 60(3):415-20. PubMed ID: 16989457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM.
    Int J Audiol; 2006 Jun 01; 45(6):337-43. PubMed ID: 16777780
    [Abstract] [Full Text] [Related]

  • 10. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ.
    Pediatr Blood Cancer; 2013 Mar 01; 60(3):474-8. PubMed ID: 22744939
    [Abstract] [Full Text] [Related]

  • 11. Early ototoxic changes in patients with germ cell tumor after first cycle of cisplatin-based therapy.
    Noszek L, Budai B, Prekopp P, Széchenyi R, Szőnyi M, Talpai S, Nagyiványi K, Bíró K, Géczi L.
    Laryngoscope; 2017 Aug 01; 127(8):E277-E282. PubMed ID: 27666741
    [Abstract] [Full Text] [Related]

  • 12. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
    Sockalingam R, Freeman S, Cherny TL, Sohmer H.
    Am J Otol; 2000 Jul 01; 21(4):521-7. PubMed ID: 10912698
    [Abstract] [Full Text] [Related]

  • 13. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G.
    Int J Pediatr Otorhinolaryngol; 2001 May 31; 59(1):47-57. PubMed ID: 11376818
    [Abstract] [Full Text] [Related]

  • 14. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct 31; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 15. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
    Daldal A, Odabasi O, Serbetcioglu B.
    Otolaryngol Head Neck Surg; 2007 Nov 31; 137(5):747-52. PubMed ID: 17967639
    [Abstract] [Full Text] [Related]

  • 16. [Hearing loss caused by high dose carboplatin therapy].
    Lautermann J, Adamczyk M, ten Cate WJ, Kloke O.
    Laryngorhinootologie; 1998 Feb 31; 77(2):82-4. PubMed ID: 9555700
    [Abstract] [Full Text] [Related]

  • 17. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM, Knief A, Lagosch AK, Deuster D, am Zehnhoff-Dinnesen A.
    Ear Hear; 2008 Dec 31; 29(6):830-7. PubMed ID: 18772725
    [Abstract] [Full Text] [Related]

  • 18. Distortion-product otoacoustic emission test performance for ototoxicity monitoring.
    Reavis KM, McMillan G, Austin D, Gallun F, Fausti SA, Gordon JS, Helt WJ, Konrad-Martin D.
    Ear Hear; 2011 Feb 31; 32(1):61-74. PubMed ID: 20625302
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
    Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L.
    Br J Cancer; 1998 Apr 31; 77(8):1355-62. PubMed ID: 9579846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.